← Scenarios

BALAMINES

Balaji Amines Limited

Chemicals: Specialty/ NSE

Compiled

Auto-generated from filings and public channels — no analyst dossier.

If management delivers what it guided

arithmetic on filed guidance and past valuations · not a price target

BALAMINES

FY26 → FY28 · 2 years of guidance · ~1.7 years from today₹2,133 today

BEAR

₹1,168

-45%-30% a yr

17.4% a year · 16.4x exit

BASE

₹1,938

-9%-6% a yr

30% a year · 22.2x exit

BULL

₹2,684

+26%+15% a yr

40.8% a year · 26.2x exit

Where the market has priced it

8x41x today — outside the range33x

the guided figure reached earnings through a low-confidence bridge
at 41x its FY26 earnings the stock already trades above the top of its own ten-year range (26x)

How these numbers are produced

Earnings base	FY26 fiscal year EPS ₹51.6 (screener)
Guided growth	30% a year, said on the call of 23-May-2026 · transcript
Read across as	operating: volume growth, realisation+margin held flat — low confidence
Delivery calibration	0.58x / 1x / 1.36x of what was guided — measured: 76 annual guided-vs-filed pairs + 77 near-complete quarterly years — NSE transcripts against the companies' own filings
Exit multiple	16.44x / 22.22x / 26.24x, this company’s own p20 / median / p80 across 10 filed years
Filed-industry peers	median 23x across 40 peers — the cross-check, not the input
Arithmetic	base EPS × (1 + guided growth × delivery)² × exit multiple

Arithmetic on management’s own guidance and this company’s own past valuations. Not a price target, not a recommendation, and not a forecast of what the stock will do.

How to read this

It answers one question. If this management delivers the growth it told its own investors it would, and the market pays what it has historically paid for this company's earnings, where does the arithmetic land? Nothing here is a forecast of the share price.
Three cases, two moving parts. Bear, base and bull vary the delivery — what fraction of guidance managements actually file — and the exit multiple together, because a company that misses its guidance is usually de-rated for missing it. Each case shows the growth rate and the multiple that produced it.
Read the width, not just the middle. A wide gap between bear and bull means the inputs are uncertain, not that the upside is bigger. A narrow range is a more confident statement than a high one.
“Where the market has priced it” puts today's P/E on the company's own historical range. Sitting far below that range is why a scenario can look enormous: the number is then mostly about re-rating, not about delivery, and the board marks those separately.
The bullets underneath are the caveats — a borrowed peer multiple, a thin filed history, an earnings base that carried a one-off. They are the reasons to trust the number less, listed rather than buried.

Not a price target, not a recommendation, and not a forecast of what the stock will do. The field guide covers the method.

What management said

from NSE earnings-call filings · extracted, not interpreted

volume growth 30%

My second question is, I did understand your 30% volume growth guidance.

Call 23-May-2026 · bridge confidence low · transcript PDF

Coverage

SectorChemicals: Specialty

Dossiersnone

Guidanceyes

Scenarioyes

Street chatter

unverified · logged from public channels

Chemicals

Tata Chemicals

Balaji Amines

Lords Chloro Alkali

Sumitomo Chemical India

Mention only27 Jul 03:37

BALAJI AMINES: Commissions India’s first commercial-scale DME plant with 1,00,000 TPA capacity at Solapur.

Capacity / capex20 May 13:29

*Elara on Balaji Amines*

Downgrade to Reduce from Accumulate

Target price raised to ₹1,696 from ₹1,339

FY27/FY28 revenue estimates raised by 17%/30%

FY27/FY28 EBITDA estimates raised by 38%/51%

Brokerage sees improved visibility on DME and BSCL projects

FY27 seen as commissioning and ramp-up year

Stock up 60% in last three months

Broker

Rating / broker19 May 04:15